PROFOUND MEDICAL CORP. Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities
PROFOUND MEDICAL CORP. (PROF) reported Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities of $187.00 thousand for the 12-month period ending 2023-12-31, per its 40-F filed 2024-03-07.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities · last filed 2024-03-07
| Period end | Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities 12 month |
|---|---|
| 2023-12-31 | $187.00K 40-F · filed 2024-03-07 |
| 2022-12-31 | -$27.00K 40-F · filed 2024-03-07 |
| 2021-12-31 | -$90.00K 40-F · filed 2023-03-07 |
| 2020-12-31 | $257.00K 40-F · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |